{
    "clinical_study": {
        "@rank": "21827", 
        "arm_group": {
            "arm_group_label": "intratympanic injection", 
            "arm_group_type": "Experimental", 
            "description": "Magnevist (gadopentetate dimeglumine, Bayer Health Care) will be diluted eightfold with sterile saline (1:7 v/v) in a 1 ml syringe and injected intra-tympanically with a 23-25g needle up to 0.4 ml or less if contrast reflux is noted under direct visualization. Anesthesia with topical phenol is available for this procedure."
        }, 
        "brief_summary": {
            "textblock": "This is a pilot study of patients with clinical symptoms of M\u00e9ni\u00e8re's disease using\n      injection of diluted magnetic resonance imaging (MRI) contrast agent into the ear to\n      evaluate inner ear structures.\n\n      The goal is to reproduce imaging findings described by non-United States (US) institutions,\n      improve on image quality with decreased scan time and evaluate the dynamics of the contrast\n      movement into the inner ear structures."
        }, 
        "brief_title": "Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Meniere's Disease", 
        "condition_browse": {
            "mesh_term": "Meniere Disease"
        }, 
        "detailed_description": {
            "textblock": "Participants will be scheduled for study sessions on 2 consecutive days to include consent,\n      baseline audiometric evaluation, intra-tympanic contrast administration, serial MR imaging,\n      and follow-up audiometry evaluation in the injected ear.\n\n      Participants over 59 years old or who have medical conditions will have a blood test to\n      check kidney function to ensure they can safely receive the contrast."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Symptoms and clinical exam consistent with M\u00e9ni\u00e8re's disease\n\n          -  Ability to undergo MR exam\n\n          -  Interest in participating in this study\n\n          -  Ability to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Children (under age 18),\n\n          -  Contraindication to MR imaging (see attached UCSD MR Screening Form)\n\n          -  Claustrophobia precluding MR exam without sedation\n\n          -  Contraindication to receiving intravenous gadolinium-based contrast agent (see\n             attached UCSD Contrast Policy)\n\n          -  Patients who are pregnant or breast feeding (intravenous contrast agents are Category\n             C)\n\n          -  Contraindication to osmotic challenge (congestive heart failure, renal failure,\n             hepatic failure)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02080312", 
            "org_study_id": "120004", 
            "secondary_id": "115,342"
        }, 
        "intervention": {
            "arm_group_label": "intratympanic injection", 
            "intervention_name": "Magnevist (gadopentetate dimeglumine)", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Meniere's disease", 
            "endolymphatic hydrops"
        ], 
        "lastchanged_date": "March 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Diego", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "92103"
                }, 
                "name": "UC San Diego Health System"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "relative volume of endolymphatic space to perilymphatic space", 
            "safety_issue": "No", 
            "time_frame": "within 24 hours post injection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02080312"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of California, San Diego", 
            "investigator_full_name": "Julie Bykowski, MD", 
            "investigator_title": "Assistant Professor, Radiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of California, San Diego", 
        "sponsors": {
            "collaborator": {
                "agency": "American Society of Head and Neck Radiology", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of California, San Diego", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}